Genzyme Corp. v. Atrium Medical Corp.

Check Treatment

Related Cases

Genzyme Corp. v. ATRIUM MEDICAL CORP.
Amgen Inc., Plaintiff-Cross v. Hoechst Marion Roussel, Inc. (Now Known as Aventis Pharmaceuticals, Inc.) and Transkaryotic Therapies, Inc.
Amgen Inc. v. Hoechst Marion Roussel, Inc. (Now Known as Aventis Pharmaceuticals Inc.)
Biovail Corporation International, Biovail Laboratories,inc., and Galephar P.R., Inc. Ltd. v. Andrx Pharmaceuticals, Inc.
Sanofi-Aventis Deutschland & GMBH v. Genentech, Inc.

ORDER

Atrium Medical Corporation moves to dismiss these appeals as premature. Atrium states that Genzyme Corporation et al. does not oppose.

Accordingly,

IT IS ORDERED THAT:

(1) The appeals are dismissed as premature.

(2) Each side shall bear its own costs.